In today’s edition of Entrepreneurship and Empowerment we are delighted to introduce Dr. Daniel Sipple, co-founder of the Mayo Clinic partnered InSitu Biologics’ sustained release drug delivery platform used in both non-opioid pain relief and monoclonal antibody delivery for cancer.
He is the inventor of the Acies Smart Needle, the only medical device designed to prevent the Medicare Never Event of inadvertent embolism which is linked to myocarditis, vaccine hesitancy and the $3.7 trillion global disease burden of long covid. He serves on the Quietmind Foundation which collaborates with Harvard in arresting and reversing dementia with photobiomodulation. As a co-founder of Hypercharge Wellness, he scales cutting edge photobiomodulation therapies for social impact.
https://www.dmu.edu/blog/2019/10/taking-an-entrepreneurial-view-of-global-health-problems/
Dr. Sipple can be reached via email at [email protected],
#aciesmedical, #hyperchargeclinics, #insitubiologcs